KamenR
2021-07-28
Not producing enough to meet demand is a great problem for any business.
Moderna Says Foreign Manufacturing Partners Facing Delays
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
11
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":803324075,"tweetId":"803324075","gmtCreate":1627423853097,"gmtModify":1633765261425,"author":{"id":3583799729432788,"idStr":"3583799729432788","authorId":3583799729432788,"authorIdStr":"3583799729432788","name":"KamenR","avatar":"https://static.tigerbbs.com/db3db81fd6b762e83625b40b8566dec3","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":37,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Not producing enough to meet demand is a great problem for any business.</p></body></html>","htmlText":"<html><head></head><body><p>Not producing enough to meet demand is a great problem for any business.</p></body></html>","text":"Not producing enough to meet demand is a great problem for any business.","highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/803324075","repostId":1170349743,"repostType":4,"repost":{"id":"1170349743","pubTimestamp":1627399823,"share":"https://www.laohu8.com/m/news/1170349743?lang=&edition=full","pubTime":"2021-07-27 23:30","market":"us","language":"en","title":"Moderna Says Foreign Manufacturing Partners Facing Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=1170349743","media":"Bloomberg","summary":"Problem has been resolved, but it has slowed release of shots\nModerna says shipping shots as it make","content":"<ul>\n <li>Problem has been resolved, but it has slowed release of shots</li>\n <li>Moderna says shipping shots as it makes them, no extra on hand</li>\n</ul>\n<p>Moderna Inc. said its Covid-19 vaccine manufacturing partners outside the U.S. are “facing delays” due to laboratory testing issues that occurred in recent days.</p>\n<p>While the problem has been resolved, it has slowed release of Moderna’s vaccine to markets outside the U.S., a company spokeswoman said in an email.</p>\n<p>The problem will cause short-term adjustments to vaccine delivery outside the U.S., she said in the email.</p>\n<p>Moderna is currently shipping vaccine as it makes it, which means it has no extra stock in storage to smooth over these types of temporary supply interruptions, spokeswoman Colleen Hussey said in an email.</p>\n<p>Shares of Moderna fell as much as 4.5% in New York trading on Tuesday.</p>\n<p>Earlier, South Korea’s prime minister said at a meeting that Moderna had notified the country that an adjustment in the vaccine supply schedule is “inevitable” due to a “production setback issue.”</p>\n<p>“We will remain in close contact with governments, recognizing the importance of delivery planning for vaccination roll-out,” Moderna said in the statement. “Moderna and its manufacturing partners are working together to minimize this shortfall across all impacted nations.”</p>\n<p>Moderna didn’t specify where the problems occurred. Its partners outside the U.S. include Lonza Group AG, which makes the vaccine substance, and Laboratorios Farmaceuticos Rovi SA in Spain, which fills vaccine vials.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Says Foreign Manufacturing Partners Facing Delays</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Says Foreign Manufacturing Partners Facing Delays\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-27 23:30 GMT+8 <a href=https://www.bloomberg.com/news/articles/2021-07-27/moderna-says-foreign-manufacturing-partners-are-facing-delays?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Problem has been resolved, but it has slowed release of shots\nModerna says shipping shots as it makes them, no extra on hand\n\nModerna Inc. said its Covid-19 vaccine manufacturing partners outside the ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-07-27/moderna-says-foreign-manufacturing-partners-are-facing-delays?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-07-27/moderna-says-foreign-manufacturing-partners-are-facing-delays?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170349743","content_text":"Problem has been resolved, but it has slowed release of shots\nModerna says shipping shots as it makes them, no extra on hand\n\nModerna Inc. said its Covid-19 vaccine manufacturing partners outside the U.S. are “facing delays” due to laboratory testing issues that occurred in recent days.\nWhile the problem has been resolved, it has slowed release of Moderna’s vaccine to markets outside the U.S., a company spokeswoman said in an email.\nThe problem will cause short-term adjustments to vaccine delivery outside the U.S., she said in the email.\nModerna is currently shipping vaccine as it makes it, which means it has no extra stock in storage to smooth over these types of temporary supply interruptions, spokeswoman Colleen Hussey said in an email.\nShares of Moderna fell as much as 4.5% in New York trading on Tuesday.\nEarlier, South Korea’s prime minister said at a meeting that Moderna had notified the country that an adjustment in the vaccine supply schedule is “inevitable” due to a “production setback issue.”\n“We will remain in close contact with governments, recognizing the importance of delivery planning for vaccination roll-out,” Moderna said in the statement. “Moderna and its manufacturing partners are working together to minimize this shortfall across all impacted nations.”\nModerna didn’t specify where the problems occurred. Its partners outside the U.S. include Lonza Group AG, which makes the vaccine substance, and Laboratorios Farmaceuticos Rovi SA in Spain, which fills vaccine vials.","news_type":1},"isVote":1,"tweetType":1,"viewCount":66,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":60,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/803324075"}
精彩评论